标题
Sequential management of postmenopausal health and osteoporosis: An update
作者
关键词
-
出版物
MATURITAS
Volume 177, Issue -, Pages 107846
出版商
Elsevier BV
发表日期
2023-09-13
DOI
10.1016/j.maturitas.2023.107846
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study
- (2023) Teerapat Tutaworn et al. OSTEOPOROSIS INTERNATIONAL
- Romosozumab and antiresorptive treatment: the importance of treatment sequence
- (2022) Felicia Cosman et al. OSTEOPOROSIS INTERNATIONAL
- Raloxifene Use After Denosumab Discontinuation Partially Attenuates Bone Loss in the Lumbar Spine in Postmenopausal Osteoporosis
- (2022) Namki Hong et al. CALCIFIED TISSUE INTERNATIONAL
- Risk of breast cancer with HRT depends on therapy type and duration
- (2022) Helen Saul et al. BMJ-British Medical Journal
- Mortality after Sustaining Skeletal Fractures in Relation to Age
- (2022) Camilla Bergh et al. Journal of Clinical Medicine
- Effects of exercise on vasomotor symptoms in menopausal women: a systematic review and meta-analysis
- (2022) T. Liu et al. CLIMACTERIC
- Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults
- (2022) Meryl S. LeBoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin D Deficiency Increases Mortality Risk in the UK Biobank
- (2022) Joshua P. Sutherland et al. ANNALS OF INTERNAL MEDICINE
- Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons
- (2022) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society
- (2022) Irene Lambrinoudaki et al. MATURITAS
- Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review
- (2021) Athanasios D. Anastasilakis et al. Journal of Clinical Medicine
- Fezolinetant in the treatment of vasomotor symptoms associated with menopause
- (2021) Herman Depypere et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide
- (2021) Angelica Lindén Hirschberg et al. MATURITAS
- Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents
- (2021) Dominik Saul et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS
- (2021) Athanasios D Anastasilakis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS—2020 UPDATE
- (2020) Pauline M. Camacho et al. Endocrine Practice
- Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
- (2020) S. Rozenberg et al. OSTEOPOROSIS INTERNATIONAL
- Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS
- (2020) Elena Tsourdi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Safety of oral bisphosphonates in moderate‐to‐severe chronic kidney disease: a bi‐national cohort analysis
- (2020) Danielle E. Robinson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
- (2019) M. Hiligsmann et al. OSTEOPOROSIS INTERNATIONAL
- Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness
- (2019) David F. Archer et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Menopause: Women should not suffer in silence
- (2019) Margaret Rees et al. MATURITAS
- Bazedoxifene for the treatment of osteoporosis
- (2019) Maria P. Yavropoulou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Effects of ospemifene on bone in postmenopausal women
- (2019) T. J. de Villiers et al. CLIMACTERIC
- Impact of osteoporotic fracture type and subsequent fracture on mortality: the Tromsø Study
- (2019) D. Alarkawi et al. OSTEOPOROSIS INTERNATIONAL
- Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
- (2019) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and meta-analysis
- (2018) Andreas Fontalis et al. Expert Opinion On Drug Safety
- Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial
- (2018) Piet Geusens et al. JOURNAL OF BONE AND MINERAL RESEARCH
- ACTIVExtend: 24 Months of Alendronate after 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
- (2018) Henry G Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dietary intake and age at natural menopause: results from the UK Women’s Cohort Study
- (2018) Yashvee Dunneram et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials
- (2018) James A. Simon et al. JOURNAL OF WOMENS HEALTH
- One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study
- (2018) E Michael Lewiecki et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause
- (2018) Colton Biehl et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Risk of subsequent fracture after prior fracture among older women
- (2018) A. Balasubramanian et al. OSTEOPOROSIS INTERNATIONAL
- Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis
- (2017) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
- (2017) Bente L Langdahl et al. LANCET
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
- (2016) Robert A Adler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)
- (2016) J. N. Tsai et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The effect of sequential therapy for postmenopausal women with osteoporosis
- (2016) Shenghan Lou et al. MEDICINE
- Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel
- (2016) Salvatore Caruso et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
- (2016) Shari S. Bassuk et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Menopause Management — Getting Clinical Care Back on Track
- (2016) JoAnn E. Manson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
- (2015) D. Edwards et al. CLIMACTERIC
- Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey
- (2015) R. E. Nappi et al. CLIMACTERIC
- Associations of Menopausal Vasomotor Symptoms with Fracture Incidence
- (2015) Carolyn J. Crandall et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Update on management of genitourinary syndrome of menopause: A practical guide
- (2015) Santiago Palacios et al. MATURITAS
- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
- (2014) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Bazedoxifene/Conjugated Estrogens on the Endometrium and Bone: A Randomized Trial
- (2014) JoAnn V. Pinkerton et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genitourinary syndrome of menopause
- (2014) David J. Portman et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A single-dose study of denosumab in patients with various degrees of renal impairment
- (2012) Geoffrey A Block et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
- (2012) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor and Cyclin D1
- (2011) J. S. Lewis-Wambi et al. MOLECULAR PHARMACOLOGY
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
- (2009) David L Kendler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*
- (2008) Stuart L Silverman et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now